Albumin News and Research

RSS
No single genetic strain associated with the worst cases of C. difficile infections

No single genetic strain associated with the worst cases of C. difficile infections

Molecular packaging enhances cancer drug’s effectiveness at destroying tumors

Molecular packaging enhances cancer drug’s effectiveness at destroying tumors

Scientists chemically synthesize ECA-derived oligosaccharides relevant for immunotherapy

Scientists chemically synthesize ECA-derived oligosaccharides relevant for immunotherapy

UC San Diego researchers identify pivotal player in diabetic kidney disease

UC San Diego researchers identify pivotal player in diabetic kidney disease

Ampio reports effects of Ampion in treating chronic pain caused by osteoarthritis of the knee

Ampio reports effects of Ampion in treating chronic pain caused by osteoarthritis of the knee

Green Cross Biotherapeutics starts construction on new biopharmaceutical facility in Montreal

Green Cross Biotherapeutics starts construction on new biopharmaceutical facility in Montreal

Lancet Diabetes & Endocrinology to publish paper on eGFR and albuminuria for prediction of cardiovascular outcomes

Lancet Diabetes & Endocrinology to publish paper on eGFR and albuminuria for prediction of cardiovascular outcomes

Measuring kidney function and damage may help predict people at risk for heart disease

Measuring kidney function and damage may help predict people at risk for heart disease

Amgen announces AMG 416 Phase 3 results for treatment of secondary hyperparathyroidism in CKD patients

Amgen announces AMG 416 Phase 3 results for treatment of secondary hyperparathyroidism in CKD patients

Aflatoxin exposure associated with increased risk of gallbladder cancer

Aflatoxin exposure associated with increased risk of gallbladder cancer

HCV-TARGET study: All-oral, direct-acting antiviral therapy for HCV effective in decompensated cirrhosis patients

HCV-TARGET study: All-oral, direct-acting antiviral therapy for HCV effective in decompensated cirrhosis patients

Regular strength training still beneficial for older people

Regular strength training still beneficial for older people

‘Most’ cirrhotic HBV patients benefit from adding adefovir to lamivudine

‘Most’ cirrhotic HBV patients benefit from adding adefovir to lamivudine

EKF introduces new diabetic biomarker test – The Stanbio Chemistry GSP LiquiColor® Assay

EKF introduces new diabetic biomarker test – The Stanbio Chemistry GSP LiquiColor® Assay

New type of engineered insulin could improve treatment for diabetes patients

New type of engineered insulin could improve treatment for diabetes patients

Study shows changes in kidney function among sugarcane workers in northwestern Nicaragua

Study shows changes in kidney function among sugarcane workers in northwestern Nicaragua

USC neuroscientists find potential prevention for Alzheimer's disease

USC neuroscientists find potential prevention for Alzheimer's disease

CytRx reports positive interim results from aldoxorubicin Phase 2 trial for treatment of GBM

CytRx reports positive interim results from aldoxorubicin Phase 2 trial for treatment of GBM

Amgen's XGEVA (denosumab) receives FDA approval for treatment of hypercalcemia of malignancy

Amgen's XGEVA (denosumab) receives FDA approval for treatment of hypercalcemia of malignancy

WSU researchers working on new system to reduce negative effects of cancer drugs

WSU researchers working on new system to reduce negative effects of cancer drugs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.